A team of researchers from the US, Europe, Taiwan and Japan has engineered a new anti-cancer agent that is about 200 times more active in killing tumor cells than similar drugs used in recent clinical trials.
Full article >>
Thursday, March 26, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment